PEA (Palmitoylethanolamide) is a naturally occurring fatty acid compound involved in inflammation regulation, nervous system signalling, mast cell activity, and recovery pathways. Micronised PEA is designed to enhance absorption and bioavailability.
This formulation is increasingly used within protocols involving chronic inflammation, MCAS (Mast Cell Activation Syndrome), Long Covid, chronic fatigue, pain syndromes, and nervous system dysregulation.
Rather than simply suppressing symptoms, PEA is thought to support the body’s own regulatory pathways involved in immune balance and nervous system signalling.
Inflammation and nervous system dysregulation sit at the centre of many chronic health presentations I see clinically — particularly Long Covid, MCAS, fatigue syndromes, chronic stress physiology, and complex recovery cases.
PEA is interesting because it supports regulation pathways without acting like a conventional pharmaceutical anti-inflammatory. I often use it as part of broader nervous system and recovery-focused protocols.
Take 2 capsules daily with food, or as advised by your practitioner.